Amicus Therapeutics has a total of 1776 patents globally, out of which 812 have been granted. Of these 1776 patents, more than 67% patents are active. The United States of America is where Amicus Therapeutics has filed the maximum number of patents, followed by Japan and Europe (EPO). Parallelly, The United States of America seems to be the main focused R&D center and also is the origin country of Amicus Therapeutics.
Amicus Therapeutics is subpart of Altria was founded in the year 2002. The company’s line of business includes the wholesale distribution of prescription drugs, proprietary drugs and toiletries.
Do read about some of the most popular patents of Amicus Therapeutics which have been covered by us in this article and also you can find Amicus Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Amicus Therapeutics patent portfolio.
How many patents does Amicus Therapeutics have?
Amicus Therapeutics has a total of 1776 patents globally. These patents belong to 163 unique patent families. Out of 1776 patents, 1191 patents are active.
How Many Patents did Amicus Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Amicus Therapeutics Applications Filed | Amicus Therapeutics Patents Granted |
2024 | – | 1 |
2023 | 19 | 85 |
2022 | 145 | 142 |
2021 | 110 | 61 |
2020 | 134 | 56 |
2019 | 111 | 62 |
2018 | 165 | 81 |
2017 | 153 | 81 |
2016 | 124 | 69 |
2015 | 94 | 66 |
2014 | 57 | 31 |
2013 | 68 | 22 |
2012 | 63 | 27 |
How many Amicus Therapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did Amicus Therapeutics File in Different Countries?
Countries in which Amicus Therapeutics Filed Patents
Country | Patents |
United States Of America | 217 |
Japan | 121 |
Europe (EPO) | 113 |
Australia | 94 |
Canada | 72 |
Korea (South) | 71 |
Hong Kong (S.A.R.) | 65 |
China | 65 |
Mexico | 56 |
Israel | 53 |
Taiwan | 52 |
Germany | 49 |
Austria | 44 |
Singapore | 43 |
Spain | 42 |
Brazil | 40 |
India | 39 |
Argentina | 37 |
New Zealand | 25 |
Denmark | 23 |
South Africa | 21 |
Portugal | 20 |
Chile | 20 |
Poland | 19 |
Colombia | 18 |
Eurasia | 18 |
Norway | 17 |
Slovenia | 17 |
Hungary | 16 |
Slovakia | 15 |
Malta | 15 |
Croatia | 14 |
Lithuania | 14 |
Cyprus | 13 |
United Kingdom | 12 |
Serbia | 12 |
Indonesia | 11 |
Estonia | 11 |
Italy | 10 |
Viet Nam | 9 |
Albania | 7 |
Malaysia | 6 |
Russia | 6 |
Philippines | 5 |
Thailand | 4 |
Panama | 4 |
San Marino | 3 |
Former Yugoslav Republic of Macedonia | 3 |
Peru | 2 |
Turkey | 2 |
Finland | 2 |
Ecuador | 1 |
Netherlands | 1 |
Tunisia | 1 |
Nicaragua | 1 |
Costa Rica | 1 |
Morocco | 1 |
Dominican Republic | 1 |
El Salvador | 1 |
Kenya | 1 |
Luxembourg | 1 |
Where are Research Centers of Amicus Therapeutics Patents Located?
10 Best Amicus Therapeutics Patents
WO2008134628A2 is the most popular patent in the Amicus Therapeutics portfolio. It has received 141 citations so far from companies like Summit Corporation Plc, Centogene Gmbh and base enzyme co Ltd.
Below is the list of 10 most cited patents of Amicus Therapeutics:
Publication Number | Citation Count |
WO2008134628A2 | 141 |
US8592362B2 | 117 |
WO2006125141A2 | 73 |
US20100113517A1 | 64 |
WO2014014938A1 | 61 |
US9056101B2 | 58 |
US7851143B2 | 53 |
WO2012154681A1 | 53 |
WO2018017721A1 | 52 |
US20140219986A1 | 49 |
What Percentage of Amicus Therapeutics US Patent Applications were Granted?
Amicus Therapeutics (Excluding its subsidiaries) has filed 136 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 108 have been granted leading to a grant rate of 87.1%.
Below are the key stats of Amicus Therapeutics patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Amicus Therapeutics?
Law Firm | Total Applications | Success Rate |
Servilla Whitney Llc | 107 | 96.00% |
Mccarter & English | 13 | 61.54% |
Amicus Therapeutics | 6 | 100.00% |
Baker Botts L L P | 4 | 0.00% |
Darby & Darby P C | 3 | 0% |
Hoffmann & Baron Llp | 3 | 0.00% |
What are Amicus Therapeutics key innovation segments?
What Technologies are Covered by Amicus Therapeutics?
The chart below distributes patents filed by Amicus Therapeutics